Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER.

MLA

Wang, Xiaowen, et al. “Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER.” Circulation, vol. 147, no. 8, Feb. 2023, pp. 624–34. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.122.062832.

APA

Wang, X., Vaduganathan, M., Claggett, B. L., Hegde, S. M., Pabon, M., Kulac, I. J., Vardeny, O., O’Meara, E., Zieroth, S., Katova, T., McGrath, M. M., Pouleur, A.-C., Jhund, P. S., Desai, A. S., Inzucchi, S. E., Kosiborod, M. N., de Boer, R. A., Kober, L., Sabatine, M. S., & Martinez, F. A. (2023). Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER. Circulation, 147(8), 624–634. https://doi.org/10.1161/CIRCULATIONAHA.122.062832

Chicago

Wang, Xiaowen, Muthiah Vaduganathan, Brian L. Claggett, Sheila M. Hegde, Maria Pabon, Ian J. Kulac, Orly Vardeny, et al. 2023. “Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER.” Circulation 147 (8): 624–34. doi:10.1161/CIRCULATIONAHA.122.062832.